Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQUAVAN for Procedural Sedation in Colonoscopy
NCT00125424Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fospropofol disodium in Procedural sedation (PS) (5 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Sedation Success Rate. Started Jul 2005; status: completed.
02
Drugs
fospropofol disodium
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT00125424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125424.